25
Participants
Start Date
August 31, 2014
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
Ticagrelor
Ticagrelor 180 mg loading dose followed by 90 mg BID for 90 days
Placebo
Placebo 180 mg loading dose followed by 90 mg BID for 90 days.
University of Maryland Medical Center, Baltimore
University of Virginia, Charlottesville
Moses Cone, Greensboro
Atlanta VA Medical Center, Atlanta
Vanderbilt University Medical Center, Nashville
University of Kentucky, Lexington
The Ohio State University, Columbus
Cleveland Clinic, Cleveland
Medical College of Wisconsin, Milwaukee
Regions Hospital, Saint Paul
Northwestern University, Chicago
Scott & White Memorial Hospital, Temple
Baylor, Houston
Memorial Hermann Hospital - Texas Medical Center, Houston
South Texas Veterans Health Care System, San Antonio
University of Texas Health Science Center San Antonio, San Antonio
Denver Health, Denver
University of Colorado, Colorado Springs
Intermountain Medical Center, Murray
University of Utah, Salt Lake City
University of Arizona, Tucson
Legacy Good Samaritan Medical Center, Portland
Legacy Emanuel Medical Center, Portland
Oregon Health Sciences University, Portland
Baystate Medical Center, Springfield
Rhode Island Hospital, Providence
Collaborators (1)
AstraZeneca
INDUSTRY
Gordon Bernard
OTHER